Related Experiment Video
Updated: May 5, 2026
07:20
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
40.0K
[Biomarkers in clinical immunology]
1Service de médecine interne, Département de médecine, CHUV, 1011 Lausanne. agnes.pardon@chuv.ch
Revue Medicale Suisse
|December 10, 2013
Summary
Immunological biomarkers aid in diagnosing complex diseases, complementing traditional methods. Tests like anti-nuclear antibodies (ANA) and rheumatoid factor (RF) enhance clinical information but do not replace patient history or physical exams.
Area of Science:
- Clinical immunology and diagnostic medicine.
- Application of laboratory testing in healthcare.
Context:
- Individualized medicine relies on accurate diagnostic tools.
- Limitations of traditional diagnostic methods like medical history and physical examination.
- Increasing reliance on laboratory tests to resolve diagnostic challenges.
Purpose:
- To analyze key immunological biomarkers used in clinical practice.
- To review the principles, utility, and performance of specific tests.
- To evaluate biomarkers such as ANA, ANCA, anti-tTG, rheumatoid factor, and anti-CCP in clinical scenarios.
Summary:
- Discusses the role of immunological biomarkers in disease identification and monitoring.
- Examines the performance of specific tests including anti-nuclear antibodies (ANA), anti-neutrophil cytoplasmic antibodies (ANCA), anti-tissue transglutaminase (anti-tTG), rheumatoid factor (RF), and anti-cyclic citrullinated peptide (anti-CCP) antibodies.
- Highlights that these biomarkers are valuable adjuncts to clinical assessment.
Impact:
- Demonstrates that immunological biomarkers significantly enhance diagnostic accuracy when integrated with clinical data.
- Emphasizes the supplementary role of laboratory tests, rather than replacement, in patient evaluation.
- Provides clinicians with insights into the effective use of common immunology tests for better patient management.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
765
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
01:27Myocarditis II: Clinical Features and Diagnostic Tests
493
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
493